Resources
Resource types
- News article
biomodal, today announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments.
- News article
Dr. Sophie Kirschner, Associate Director, Translational Medicine, Early Oncology at AstraZeneca will present data using biomodal’s 6-base multiomics sequencing solution, duet evoC.
- News article
Distinguishing 5mC and 5hmC, enabled through duet evoC and the 6-base genome, delivered an AUC of 0.95 for stage I colorectal cancer from liquid biopsy, improving the earlier detection of stage I colorectal cancer from cfDNA samples!
- News article
biomodal has debuted in the top 10 of The Sunday Times Top 100 Tech Companies 2026.
- Product sheet
Download the product sheet for modality XPLR today.
- News article
biomodal announced it has filed a lawsuit against Watchmaker Genomics (“Watchmaker”) in the US District Court for the District of Colorado.
- Blog post
Explore the importance of epigenetics and how it shapes health, disease, and precision medicine through gene regulation, and DNA methylation.
- Poster
This study demonstrates the value of moving beyond legacy epigenetic sequencing technologies that provide a modC readout.
- Poster
Using modality XPLR, we reveal variation in 5mC and 5hmC levels across tissues, with a pronounced increase in 5hmC in cerebellum and concomitant decrease in 5mC.
- Poster
Patterns of 5hmC and 5hmC provide insight into tissue-specific gene expression with the ability to better distinguish high and low expressed genes than 5mC or 5modC data.
- Poster
This poster demonstrates compatibility of duet evoC with formalin-damaged DNA including clinical FFPE samples.
- Scientific presentation
modality XPLR is an accessible and scalable software tool designed for scientists and translational researchers to uncover disease-relevant epigenetic signatures, link methylation to gene regulation, and support biomarker discovery—empowering you to identify, classify, and monitor disease.